Haematologica 2000; 85:E04

[prev] [index] [next]

Erythropoietin doping. A comment.
Angel F. Remacha
Hematology Department. Hospital de Sant Pau. Barcelona. Spain.


Correspondence: Dr Angel F. Remacha, Hematology department, Hospital de Sant Pau, Avda Padre Claret 167. Barcelona 08013 Spain. E-mail: 2107@hsp.santpau.es

medline ref.
Detection of erythropoietin abuse is an old chesnut in an Olympic year.1 In this regard, I have read with interest the two excellent works2,3 on blood doping with erythropoietin published in Haematologica. Nevertheless, I should like to make the following aspects, I agree that the use of Hct or Hb as the only criterion for detecting rHuEpo doping is not the best methodology. Accordingly, the work in Haematologica (3) demostrates that more than 50% of cases during the treatment would not be detected using the Hct or Hb, which is the procedure accepted by International Sports Authorities.1 The proposed model to detect erythropoietin abuse is very complicated and simplification is advisable.3 Looking at the variables and their coefficients, it is very probable that, using a multivariate approach, some of the variables will be redundant.
Apart from the strict statistical approach, it is important to include biological and practical criteria. In this regard, it is advisable to employ variables that could be determined using several methodologies and not to depend on a specific analyzer. Markers related to iron metabolism and erythropoeisis (ferritin, transferrin receptor, serum erythropoietin, reticulocytes and their maturity fractions) are widely used and their clinical diagnostic value is well known. Moreover, results could be obtained in minutes and with an excellent reproductibility. By constrast, other factors such as new reticulocyte related variables are very interesting, but less utilised and more difficult to evaluate. Variations in these parameters during the different phases of exercise (training, competition, etc.) have been demonstrated,4 and these could affect the diagnostic value of these models. For instance, it is well known that urine and serum erythropoietin,5 reticulocytes, ferritin and other parameters undergo changes depending on the phase of competition.4
Bearing in mind the controversial reactions produced by the use of Hct or Hb, before one of these models is definitively adopted, prudence is the best advice, even when we know that these models are far better than the ones adopted by Sports Authorities.

References

  1. Badía R, Remacha A, de la Torre R, Segura J. Erythropoietin detection in biological fluids. 2nd IOC World Congress on Sport Sciences. Barcelona October 1991.
  2. Cazzola M. A global strategy for prevention and detection of blood doping with erythropoietin and realted drugs. Haematologica 2000; 85: 561-3.
  3. Parisotto R, Gore CJ, Emslie KR, et al. A novel method utilising markers of altered erythropoiesis for the detection of recombinat human erythropoietin abuse in athletes. Haematologica 2000; 85: 564-72.
  4. Remacha AF, Ordoñez J, García-Die F, Estruch A, Gimferrer E. Cambios hematológicos inducidos por el ejercicio durante una carrera de largas distancias. Sangre 1993; 38: 443-447.
  5. Remacha AF, Ordoñez J, Barceló MJ, García-Die F, Arza B, Estruch A. Evaluation of erythropoietin in endurance runners. Haematologica 1994; 79: 350-352.